Matthew K. Szot

Insider Reports History

Entity
Individual
Location
802 North Douty Street, Hanford, CA
Signature
/s/ Thomas C. Chesterman, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Matthew K. Szot:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Cadrenal Therapeutics, Inc. Chief Financial Officer Common Stock 500K $345K $0.69 Jan 24, 2023 Direct
S&W Seed Co EVP Finance & Admin and CFO Common Stock 138K $73.1K $0.53 Oct 5, 2021 Direct
SenesTech, Inc. Director Stock Option (right to buy) 12.1K $37.3K $0.95 Aug 27, 2024 Direct
Cadrenal Therapeutics, Inc. Chief Financial Officer Stock Options 250K Jan 18, 2024 Direct
INVO Bioscience, Inc. Director Stock Option (right to buy) 85K May 18, 2023 Direct
S&W Seed Co EVP Finance & Admin and CFO Stock option (right to buy) 80K Oct 5, 2021 Direct

Insider Reports Filed by Matthew K. Szot

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SNES SenesTech, Inc. Aug 27, 2024 1 $0 4 Aug 28, 2024 Director
CVKD Cadrenal Therapeutics, Inc. Jan 18, 2024 1 $0 4 Jan 19, 2024 Chief Financial Officer
SNES SenesTech, Inc. Jun 26, 2023 1 $0 4 Jun 29, 2023 Director
INVO INVO Bioscience, Inc. May 18, 2023 1 $0 4 May 22, 2023 Director
CVKD Cadrenal Therapeutics, Inc. Jan 24, 2023 1 $0 4 Jan 24, 2023 Chief Financial Officer
CVKD Cadrenal Therapeutics, Inc. Jan 19, 2023 0 $0 3 Jan 19, 2023 Chief Financial Officer
SNES SenesTech, Inc. Jul 1, 2022 1 $0 4 Jul 6, 2022 Director
INVO INVO Bioscience, Inc. Jun 1, 2022 1 $13.8K 4 Jun 3, 2022 Director
INVO INVO Bioscience, Inc. Jan 15, 2022 2 $0 4 Jan 18, 2022 Director
SANW S&W Seed Co Oct 5, 2021 2 $0 4 Oct 7, 2021 EVP Finance & Admin and CFO
SANW S&W Seed Co Oct 1, 2021 1 -$3.83K 4 Oct 4, 2021 EVP Finance & Admin and CFO
SANW S&W Seed Co Jul 1, 2021 3 -$6.68K 4 Jul 6, 2021 EVP Finance & Admin and CFO
SNES SenesTech, Inc. Jun 25, 2021 1 $0 4 Jun 29, 2021 Director